$CRKN
Crown Electrokinetics Corp. Stock $crkn

$crkn Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121390023087009 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$94.00K		$0.00
YoY Change
Cost Of Revenue	$832.0K
YoY Change
Gross Profit	-$738.0K
YoY Change
Gross Profit Margin	-785.11%
Selling, General & Admin	$4.036M	$2.941M	$2.160M
YoY Change	70.51%	36.16%	-55.6%
% of Gross Profit
Research & Development	$708.0K	$492.0K	$955.0K
YoY Change	21.23%	-48.48%	21.35%
% of Gross Profit
Depreciation & Amortization	$193.0K	$100.0K	$69.00K
YoY Change	34.97%	44.93%	-4.17%
% of Gross Profit
Operating Expenses	$5.477M	$3.433M	$3.115M
YoY Change	85.6%	10.21%	-44.89%
Operating Profit	-$6.215M	-$3.433M	-$3.115M
YoY Change		10.21%	-44.89%
Interest Expense	-$2.447M	$2.445M	$1.000K
YoY Change	1531.33%	244400.0%	-150.0%
% of Operating Profit
Other Income/Expense, Net	$5.000K	$574.0K	-$1.000K
YoY Change	-99.47%	-57500.0%	-97.96%
Pretax Income	-$9.306M	-$2.859M	-$3.116M
YoY Change	332.43%	-8.25%	-45.36%
Income Tax
% Of Pretax Income
Net Earnings	-$9.506M	-$2.859M	-$3.116M
YoY Change	335.26%	-8.25%	-45.36%
Net Earnings / Revenue	-10112.77%
Basic Earnings Per Share		-$0.94	-$0.18
Diluted Earnings Per Share	-$0.56	-$0.94	-$0.18
COMMON SHARES
Basic Shares Outstanding	12.64M shares	3.019M shares	15.87M shares
Diluted Shares Outstanding		3.349M shares	17.64M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.059M	$2.060M	$342.0K
YoY Change	28.99%	502.34%	-96.47%
Cash & Equivalents	$1.059M	$2.056M	$342.0K
Short-Term Investments
Other Short-Term Assets	$728.0K	$96.00K	$380.0K
YoY Change	1055.56%	-74.74%	-46.1%
Inventory
Prepaid Expenses
Receivables	$83.00K
Other Receivables	$0.00
Total Short-Term Assets	$1.870M	$2.662M	$722.0K
YoY Change	32.53%	268.7%	-93.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.830M	$2.638M	$1.416M
YoY Change	242.8%	86.3%	192.56%
Goodwill	$652.0K	$652.0K
YoY Change
Intangibles		$1.633M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.445M	$33.00K	$403.0K
YoY Change	702.78%	-91.81%	1339.29%
Total Long-Term Assets	$7.657M	$9.504M	$5.444M
YoY Change	47.85%	74.58%	137.21%
TOTAL ASSETS
Total Short-Term Assets	$1.870M	$2.662M	$722.0K
Total Long-Term Assets	$7.657M	$9.504M	$5.444M
Total Assets	$9.527M	$12.17M	$6.166M
YoY Change	44.57%	97.31%	-51.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.500M	$1.855M	$1.211M
YoY Change	73.41%	53.18%	184.27%
Accrued Expenses	$1.767M	$175.0K	$133.0K
YoY Change	184.54%	31.58%	-72.29%
Deferred Revenue	$2.000K
YoY Change
Short-Term Debt	$429.0K	$90.00K	$8.000K
YoY Change	-74.19%	1025.0%	-98.18%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.776M	$2.537M	$1.605M
YoY Change	-19.56%	58.07%	19.33%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.074M	$360.0K	$1.815M
YoY Change	-21.38%	-80.17%
Total Long-Term Liabilities	$1.074M	$360.0K	$1.815M
YoY Change	-21.38%	-80.17%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.776M	$2.537M	$1.605M
Total Long-Term Liabilities	$1.074M	$360.0K	$1.815M
Total Liabilities	$4.850M	$2.892M	$3.420M
YoY Change	-19.97%	-15.44%	154.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$117.0M	-$107.7M	-$85.85M
YoY Change	32.95%	25.45%
Common Stock	$7.000K	$7.000K	$2.000K
YoY Change	250.0%	250.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.677M	$9.274M	$2.746M
YoY Change
Total Liabilities & Shareholders Equity	$9.527M	$12.17M	$6.166M
YoY Change	44.57%	97.31%	-51.45%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$9.506M	-$2.859M	-$3.116M
YoY Change	335.26%	-8.25%	-45.36%
Depreciation, Depletion And Amortization	$193.0K	$100.0K	$69.00K
YoY Change	34.97%	44.93%	-4.17%
Cash From Operating Activities	-$4.350M	-$3.420M	-$2.106M
YoY Change	40.73%	62.39%	-15.69%
INVESTING ACTIVITIES
Capital Expenditures	$1.093M	$370.0K	-$20.00K
YoY Change	131.08%	-1950.0%	-95.66%
Acquisitions
YoY Change
Other Investing Activities	$5.000K	-$10.00K
YoY Change
Cash From Investing Activities	-$1.088M	-$380.0K	-$20.00K
YoY Change	130.02%	1800.0%	-95.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.444M	5.820M	1.484M
YoY Change	9.92%	292.18%	715.38%
NET CHANGE
Cash From Operating Activities	-4.350M	-3.420M	-2.106M
Cash From Investing Activities	-1.088M	-380.0K	-20.00K
Cash From Financing Activities	4.444M	5.820M	1.484M
Net Change In Cash	-994.0K	2.020M	-642.0K
YoY Change	-307.52%	-414.64%	-76.88%
FREE CASH FLOW
Cash From Operating Activities	-$4.350M	-$3.420M	-$2.106M
Capital Expenditures	$1.093M	$370.0K	-$20.00K
Free Cash Flow	-$5.443M	-$3.790M	-$2.086M
YoY Change	52.72%	81.69%	2.41%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
	crkn	Hudson Warrant HudsonWarrant	86000	usd
	crkn	Hudson Warrant HudsonWarrant	85000	usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	333-232426
	dei	Entity Registrant Name EntityRegistrantName	Crown Electrokinetics Corp.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-5423944
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1110 NE Circle Blvd
	dei	Entity Address City Or Town EntityAddressCityOrTown	Corvallis
	dei	Entity Address State Or Province EntityAddressStateOrProvince	OR
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	97330
	dei	City Area Code CityAreaCode	213
	dei	Local Phone Number LocalPhoneNumber	660.4250
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12636555	shares
	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value
	dei	Trading Symbol TradingSymbol	CRKN
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2056000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	821000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	606000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	590000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	2662000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1411000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2638000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1409000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1633000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1598000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	701000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1842000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	652000	usd
CY2023Q3	us-gaap	Deferred Costs DeferredCosts	3847000	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	150000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	33000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	180000	usd
CY2023Q3	us-gaap	Assets Assets	12166000	usd
CY2022Q4	us-gaap	Assets Assets	6590000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1855000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	865000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	175000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	621000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	385000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	574000	usd
CY2023Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	34000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	972000	usd
CY2022Q4	crkn	Notes Payable At Fair Value NotesPayableAtFairValue	1654000	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	88000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	8000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2537000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4694000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	355000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1366000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	2892000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	6060000	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6880049	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	338033	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	116956000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	88533000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-107689000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-88005000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	9274000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	530000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12166000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6590000	usd
	us-gaap	Revenues Revenues	59000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	54000	usd
	us-gaap	Gross Profit GrossProfit	5000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	492000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	955000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1523000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3523000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2941000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2160000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10926000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8634000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	3433000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	3115000	usd
	us-gaap	Operating Expenses OperatingExpenses	12449000	usd
	us-gaap	Operating Expenses OperatingExpenses	12157000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3433000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3115000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12444000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12157000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	2445000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	1000	usd
	us-gaap	Interest Expense InterestExpense	6970000	usd
	us-gaap	Interest Expense InterestExpense	6000	usd
	crkn	Loss On Extinguishment Of Warrant Liability LossOnExtinguishmentOfWarrantLiability	504000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2345000	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	64000	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2688000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-10424000	usd
CY2023Q3	crkn	Change In Fair Value Of Notes1 ChangeInFairValueOfNotes1	-40000	usd
	crkn	Change In Fair Value Of Notes1 ChangeInFairValueOfNotes1	-7040000	usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	401000	usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	401000	usd
CY2023Q3	us-gaap	Other Expenses OtherExpenses	30000	usd
	us-gaap	Other Expenses OtherExpenses	1264000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	574000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7234000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2859000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3116000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19678000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12163000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2859000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3116000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-19678000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12163000	usd
	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	6000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3142000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3139000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20154000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12186000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.94
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-11.76
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-12.96
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-48.58
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3349195	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	266872	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1554554	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	250832	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	530000	usd
	crkn	Exercise Of Common Stock Warrants ExerciseOfCommonStockWarrants	2062000	usd
	crkn	Issuance Of Common Stock In Connection With Conversion Of Notes1 IssuanceOfCommonStockInConnectionWithConversionOfNotes1	516000	usd
	crkn	Issuance Of Common Stock In Connection With Equity Line Of Credit IssuanceOfCommonStockInConnectionWithEquityLineOfCredit	4489000	usd
	crkn	Stock Issue Duringperiod Value Issuance Of Common Stock Atthemarket Offering Net Of Offering Costs StockIssueDuringperiodValueIssuanceOfCommonStockAtthemarketOfferingNetOfOfferingCosts	3787000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	4350000	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	298000	usd
	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	1000	usd
	crkn	Issuance Of Common Stock In Connection With Conversion Of2022 Notes IssuanceOfCommonStockInConnectionWithConversionOf2022Notes	2166000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	450000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	1276000	usd
	crkn	Conversion Of Senior Secured Notes Into Series F Preferred Stock In Connection With Exchange ConversionOfSeniorSecuredNotesIntoSeriesFPreferredStockInConnectionWithExchange	82000	usd
	crkn	Stock Issued During Period Value Issuance Of Series F1 Preferred Stock StockIssuedDuringPeriodValueIssuanceOfSeriesF1PreferredStock	1372000	usd
	crkn	Stock Issued During Period Value Issuance Of Series F2 Preferred Stock StockIssuedDuringPeriodValueIssuanceOfSeriesF2PreferredStock	464000	usd
	crkn	Commitment To Issue Shares Of Common Stock In Connection With Senior Secured Notes CommitmentToIssueSharesOfCommonStockInConnectionWithSeniorSecuredNotes	2410000	usd
	crkn	Stock Issued During Period Value Credit Notes Common Stock Commitment Share Issuance StockIssuedDuringPeriodValueCreditNotesCommonStockCommitmentShareIssuance	230000	usd
	crkn	Stock Issued Durign Period Commitment To Issue Shares Of Series E Preferred Stock In Connection With Line Of Credit Notes StockIssuedDurignPeriodCommitmentToIssueSharesOfSeriesEPreferredStockInConnectionWithLineOfCreditNotes	3363000	usd
	crkn	Stock Issued Durign Period Commitment To Issue Shares Of Common Stock In Connection With Demand Notes StockIssuedDurignPeriodCommitmentToIssueSharesOfCommonStockInConnectionWithDemandNotes	286000	usd
	crkn	Stock Issued During Period Value Of Common Stock In Connection With Senior Secured Notes Settlement StockIssuedDuringPeriodValueOfCommonStockInConnectionWithSeniorSecuredNotesSettlement	1160000	usd
	crkn	Issuance Of Common Stock In Connections With Equity Line Of Credit IssuanceOfCommonStockInConnectionsWithEquityLineOfCredit	114000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	446000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-19678000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	9274000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8988000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	1000	usd
	crkn	Stock And Warrants Issued During Period Value Of Common Stock Net Of Fees StockAndWarrantsIssuedDuringPeriodValueOfCommonStockNetOfFees	855000	usd
	crkn	Stock Issuance Of Common Stock Warrants In Connection With Sloc StockIssuanceOfCommonStockWarrantsInConnectionWithSLOC	223000	usd
	crkn	Stock Issued During The Period Preferred Stock And Warrants Net Of Fees Value StockIssuedDuringThePeriodPreferredStockAndWarrantsNetOfFeesValue	1039000	usd
	crkn	Stock Issue Duringperiod Value Issuance Of Common Stock Atthemarket Offering Net Of Offering Costs StockIssueDuringperiodValueIssuanceOfCommonStockAtthemarketOfferingNetOfOfferingCosts	706000	usd
	crkn	Stock Issued During Period Value Of Common Stock Warrants In Connection With Consideration Payable StockIssuedDuringPeriodValueOfCommonStockWarrantsInConnectionWithConsiderationPayable	86000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3011000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12163000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	2746000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	4557000	usd
CY2023Q3	crkn	Stock Issued During Period Value Of Common Stock In Connection With Senior Secured Notes Settlement StockIssuedDuringPeriodValueOfCommonStockInConnectionWithSeniorSecuredNotesSettlement	1160000	usd
CY2023Q3	crkn	Issuance Of Common Stock In Connection With Equity Line Of Credit IssuanceOfCommonStockInConnectionWithEquityLineOfCredit	114000	usd
CY2023Q3	crkn	Stock Issuance Of Common Stockequity Line Of Credit Net Of Offering Costs StockIssuanceOfCommonStockequityLineOfCreditNetOfOfferingCosts	4489000	usd
CY2023Q3	crkn	Stock Issue Duringperiod Value Issuance Of Common Stock Atthemarket Offering Net Of Offering Costs StockIssueDuringperiodValueIssuanceOfCommonStockAtthemarketOfferingNetOfOfferingCosts	1680000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	133000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2859000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	9274000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	2753000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	1000	usd
CY2022Q3	crkn	Stock And Warrants Issued During Period Value Of Common Stock Net Of Fees StockAndWarrantsIssuedDuringPeriodValueOfCommonStockNetOfFees	855000	usd
CY2022Q3	crkn	Stock Issued During The Period Preferred Stock And Warrants Net Of Fees Value StockIssuedDuringThePeriodPreferredStockAndWarrantsNetOfFeesValue	1039000	usd
CY2022Q3	crkn	Stock Issue Duringperiod Value Issuance Of Common Stock Atthemarket Offering Net Of Offering Costs StockIssueDuringperiodValueIssuanceOfCommonStockAtthemarketOfferingNetOfOfferingCosts	648000	usd
CY2022Q3	crkn	Stock Issued During Period Value Of Common Stock Warrants In Connection With Consideration Payable StockIssuedDuringPeriodValueOfCommonStockWarrantsInConnectionWithConsiderationPayable	86000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	480000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3116000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	2746000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-19678000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12163000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	446000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3011000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	542000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	360000	usd
	crkn	Loss On Extinguishment Of Warrant Liability LossOnExtinguishmentOfWarrantLiability	504000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-10424000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	401000	usd
	crkn	Gain On Issuance Of Convertible Note GainOnIssuanceOfConvertibleNote	64000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2345000	usd
	crkn	Change In Fair Value Of Notes ChangeInFairValueOfNotes	-7040000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	6800000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1141000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	365000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	467000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-380000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-52000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-136000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-392000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	732000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	367000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-575000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-165000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1200000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-268000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11809000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8049000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	645000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1084000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	278000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	61000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1729000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-339000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2062000	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	855000	usd
	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	3957000	usd
	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	732000	usd
	crkn	Proceeds From The Issuance Of Q3 Demand Notes ProceedsFromTheIssuanceOfQ3DemandNotes	2350000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	170000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	26000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1039000	usd
	crkn	Proceeds From Issuance Of Series F1 Preferred Stock Net Of Fees ProceedsFromIssuanceOfSeriesF1PreferredStockNetOfFees	2328000	usd
	crkn	Proceeds From Issuance Of Series F2 Preferred Stock ProceedsFromIssuanceOfSeriesF2PreferredStock	748000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1357000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2348000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4489000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14773000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2600000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1235000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-5788000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	821000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6130000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2056000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	342000	usd
	crkn	Issuance Of Series E Preferred Stock In Connection With Line Of Credit IssuanceOfSeriesEPreferredStockInConnectionWithLineOfCredit	4350000	usd
	crkn	Issuance Of Common Stock In Connection With Equity Line Of Credits IssuanceOfCommonStockInConnectionWithEquityLineOfCredits	114000	usd
	crkn	Issuance Of Series F Preferred Stock In Connection With Exchange Of Series D Preferred Stock IssuanceOfSeriesFPreferredStockInConnectionWithExchangeOfSeriesDPreferredStock	450000	usd
	crkn	Issuance Of Common Stock In Connection With Conversion Of Notes IssuanceOfCommonStockInConnectionWithConversionOfNotes	2681000	usd
	crkn	Issuance Of Common Stock In Connection With Senior Secured Notes Settlement IssuanceOfCommonStockInConnectionWithSeniorSecuredNotesSettlement	1160000	usd
	crkn	Issuance Of Common Stock Warrants In Connection With Sloc IssuanceOfCommonStockWarrantsInConnectionWithSLOC	223000	usd
	crkn	Conversion Of Senior Secured Notes Into Series F Preferred Stock In Connection With Exchange ConversionOfSeniorSecuredNotesIntoSeriesFPreferredStockInConnectionWithExchange	82000	usd
	crkn	Commitment To Issue Shares Of Common Stock In Connection With Demand Notes CommitmentToIssueSharesOfCommonStockInConnectionWithDemandNotes	286000	usd
	crkn	Unpaid Equipment Included In Accounts Payable UnpaidEquipmentIncludedInAccountsPayable	23000	usd
	crkn	Unpaid Equipment Included In Accounts Payable UnpaidEquipmentIncludedInAccountsPayable	486000	usd
	crkn	Issuance Of Common Stock Warrants In Connection With Consideration Payable IssuanceOfCommonStockWarrantsInConnectionWithConsiderationPayable	86000	usd
	us-gaap	Interest Paid Net InterestPaidNet	9000	usd
	us-gaap	Interest Paid Net InterestPaidNet	3000	usd
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2015-04-20
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-107700000	usd
CY2023Q3	us-gaap	Cash Cash	2100000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-19700000	usd
	crkn	Net Cash Provided By Used In Operating Activitie NetCashProvidedByUsedInOperatingActivitie	11800000	usd
CY2023Q3	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	10000000	usd
CY2023Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	100000000	usd
	crkn	Equity Line Of Credit EquityLineOfCredit	50000000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The preparation of condensed financial statements in conformity with GAAP requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenue and expenses during the reporting periods. Accounting estimates and assumptions are inherently uncertain. Management bases its estimates and assumptions on current facts, historical experience and various other factors believed to be reasonable under the circumstances. Actual results could differ materially and adversely from these estimates. Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include, but not limited to, valuation of its business combination, estimated fair value of convertible notes, estimated fair value of warrant lability, Series F/F-1/F-2 preferred stock, stock option awards for stock-based compensation and operating lease right-of-use assets and liabilities.</span></p>
	crkn	Percentage Of Payment Invoices PercentageOfPaymentInvoices	0.05	pure
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3620749	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	359847	shares
CY2023Q1	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	700000	usd
CY2023Q3	us-gaap	Defined Contribution Plan Number Of Employees DefinedContributionPlanNumberOfEmployees	12	pure
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	655000	usd
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	200000	usd
	crkn	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Security Deposits BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSecurityDeposits	5000	usd
	crkn	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accrued Expenses BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses	529000	usd
	crkn	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Notes Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayable	338000	usd
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	7000	usd
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	652000	usd
	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	645000	usd
	us-gaap	Proceeds From License Fees Received ProceedsFromLicenseFeesReceived	176000	usd
	us-gaap	Proceeds From License Fees Received ProceedsFromLicenseFeesReceived	300000	usd
	us-gaap	Professional Fees ProfessionalFees	189000	usd
	us-gaap	Proceeds From Insurance Settlement Operating Activities ProceedsFromInsuranceSettlementOperatingActivities	59000	usd
	us-gaap	Proceeds From Insurance Settlement Operating Activities ProceedsFromInsuranceSettlementOperatingActivities	142000	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	96000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	63000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	606000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	590000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3477000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1871000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	839000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	462000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2638000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1409000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	100000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	100000	usd
	us-gaap	Depreciation Depreciation	300000	usd
	us-gaap	Depreciation Depreciation	200000	usd
CY2023Q3	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1800000	usd
CY2022Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1800000	usd
CY2023Q3	crkn	Finite Lived Intangible Assets Research License Gross FiniteLivedIntangibleAssetsResearchLicenseGross	375000	usd
CY2022Q4	crkn	Finite Lived Intangible Assets Research License Gross FiniteLivedIntangibleAssetsResearchLicenseGross	375000	usd
CY2023Q3	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	200000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2375000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2175000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	742000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	577000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1633000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1598000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	66000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	235000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	234000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	197000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	901000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1633000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	usd
CY2023Q3	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Gross DebtIssuanceCostsLineOfCreditArrangementsGross	10648000	usd
CY2022Q4	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Gross DebtIssuanceCostsLineOfCreditArrangementsGross	223000	usd
CY2023Q3	us-gaap	Accumulated Amortization Of Debt Issuance Costs Line Of Credit Arrangements AccumulatedAmortizationOfDebtIssuanceCostsLineOfCreditArrangements	6801000	usd
CY2022Q4	us-gaap	Accumulated Amortization Of Debt Issuance Costs Line Of Credit Arrangements AccumulatedAmortizationOfDebtIssuanceCostsLineOfCreditArrangements	73000	usd
CY2023Q3	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	3847000	usd
CY2022Q4	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	150000	usd
CY2023Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	115000	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	510000	usd
CY2023Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	49000	usd
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	104000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	11000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	175000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	621000	usd
	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	592137	shares
	us-gaap	Stock Option Exercise Price Decrease StockOptionExercisePriceDecrease	8.868
CY2023Q3	us-gaap	Convertible Preferred Stock Shares Reserved For Future Issuance ConvertiblePreferredStockSharesReservedForFutureIssuance	2930	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2023Q3	crkn	Aggregate Amount AggregateAmount	50000000	usd
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.0499	pure
	crkn	Purchase Price Of Common Stock Percentage PurchasePriceOfCommonStockPercentage	0.97	pure
CY2023Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	34000	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1654000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	972000	usd
CY2023Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	2600000	usd
	crkn	Shares Of Common Stock SharesOfCommonStock	248981	shares
	crkn	Fair Value Converted Notes FairValueConvertedNotes	2200000	usd
	crkn	Change In Fair Value ChangeInFairValue	400000	usd
CY2023Q1	crkn	Withdrew Amount WithdrewAmount	2000000	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2000000	usd
CY2023Q3	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	400000	usd
CY2023Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	362657	shares
	crkn	Warrants Exercised WarrantsExercised	106764	shares
CY2023Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	96980	shares
CY2022	crkn	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm	2022-12-31
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.487	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0474	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P0Y9M18D
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	crkn	Aggregate Principal Amount AggregatePrincipalAmount	600000	usd
CY2023Q3	us-gaap	Shares Issued SharesIssued	576	shares
	crkn	Eloc Purchase Agreement Description ELOCPurchaseAgreementDescription	the Company issued 21,841 shares of common stock to the ELOC Purchase as an initial fee for commitment to purchase the Company’s common stock under the ELOC Purchase Agreement. On the date that is the earlier of (i) 30 calendar days after the Closing Date or (2) October 16, 2023, the Company will issue an additional 87,417 shares of common stock as additional commitment shares. Liability for common stock issued was $0.4 million as of the closing date. The liability is subject to remeasurement at each reporting period until issued, and any change in fair value is recognized and included as other income (expense) in the condensed consolidated statement of operations. The change in fair value of liability issued was approximately $0.4 million during the nine months ended September 30, 2023.
CY2023Q3	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	3986991	shares
CY2023Q3	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	4500000	usd
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.19
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	70000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	159295	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	153.35
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y6M
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	26188	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1516	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	196.86
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	157779	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	157.47
	crkn	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractua SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractua	P5Y9M18D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	143325	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	168.04
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y6M
CY2023Q3	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	46000	usd
CY2022Q3	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	136000	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	150000	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	636000	usd
CY2023Q3	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	87000	usd
CY2022Q3	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	344000	usd
	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	296000	usd
	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	2375000	usd
CY2023Q3	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	133000	usd
CY2022Q3	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	480000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	446000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	3011000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	10483	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	82.02
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	3344	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	104.04
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	7139	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	71.68
CY2022Q4	crkn	Share Based Compensations Arrangement By Share Based Payment Award Warrants Outstanding ShareBasedCompensationsArrangementByShareBasedPaymentAwardWarrantsOutstanding	461066	shares
CY2022Q4	crkn	Share Based Compensation Arrangement By Share Based Payment Award Warrant Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantOutstandingWeightedAverageExercisePrice	44.88
CY2022Q4	crkn	Sharebased Compensation Arrangement By Sharebased Payment Award Warrant Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantOutstandingWeightedAverageRemainingContractualTerm2	P4Y6M
	crkn	Share Based Compensation Arrangement By Share Based Payment Award Warrants Issued ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsIssued	1405797	shares
CY2023Q3	crkn	Share Based Compensation Arrangement By Share Based Payment Award Warrant Issued Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantIssuedWeightedAverageExercisePrice	11.42
CY2023Q3	crkn	Sharebased Compensation Arrangement By Sharebased Payment Award Options Issued Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsIssuedWeightedAverageRemainingContractualTerm	P4Y7M6D
	crkn	Share Based Compensation Arrangement By Share Based Payment Award Warrants Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercised	-106768	shares
CY2023Q3	crkn	Share Based Compensation Arrangement By Share Based Payment Award Warrant Exercised Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantExercisedWeightedAverageExercisePrice	19.2
CY2023Q3	crkn	Share Based Compensations Arrangement By Share Based Payment Award Warrants Outstanding ShareBasedCompensationsArrangementByShareBasedPaymentAwardWarrantsOutstanding	1760095	shares
CY2023Q3	crkn	Share Based Compensation Arrangement By Share Based Payment Award Warrant Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantOutstandingWeightedAverageExercisePrice	18.96
CY2023Q3	crkn	Sharebased Compensation Arrangement By Sharebased Payment Award Warrant Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantOutstandingWeightedAverageRemainingContractualTerm2	P4Y4M24D
CY2023Q1	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	96894	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	19.3
CY2022Q3	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	100000	usd
CY2022Q3	crkn	Aggregate Purchase Shares AggregatePurchaseShares	5000	shares
CY2022Q3	us-gaap	Share Price SharePrice	45
	crkn	Warrant Fair Value WarrantFairValue	200000	usd
CY2023Q3	us-gaap	Prepaid Royalties PrepaidRoyalties	100000	usd
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	3333	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	120
CY2022Q1	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	200000	usd
CY2023Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	700000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	108000	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	190000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	439000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	570000	usd
CY2023Q3	us-gaap	Variable Lease Cost VariableLeaseCost	25000	usd
CY2022Q3	us-gaap	Variable Lease Cost VariableLeaseCost	17000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	74000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	33000	usd
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	133000	usd
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	207000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	513000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	603000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	513000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	570000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2336000	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y8M12D
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y6M
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.12	pure
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.12	pure
CY2023Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	133000	usd
CY2023Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	417000	usd
CY2023Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	194000	usd
CY2023Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	100000	usd
CY2023Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	9000	usd
CY2023Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	853000	usd
CY2023Q3	crkn	Operating Leases Future Minimum Payments Present Value Discount OperatingLeasesFutureMinimumPaymentsPresentValueDiscount	113000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	740000	usd
	crkn	Net Proceeds NetProceeds	5456699	shares
CY2023Q3	crkn	Commission And Expenses CommissionAndExpenses	100000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased	0.36
CY2023Q3	us-gaap	Share Price SharePrice	1
CY2022Q4	us-gaap	Goodwill Goodwill		usd
CY2023Q3	crkn	Notes Payable At Fair Value NotesPayableAtFairValue		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Revenues Revenues		usd
CY2022Q3	us-gaap	Revenues Revenues		usd
	us-gaap	Revenues Revenues		usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023Q3	us-gaap	Gross Profit GrossProfit		usd
CY2022Q3	us-gaap	Gross Profit GrossProfit		usd
	us-gaap	Gross Profit GrossProfit		usd
CY2023Q3	crkn	Loss On Extinguishment Of Warrant Liability LossOnExtinguishmentOfWarrantLiability		usd
CY2022Q3	crkn	Loss On Extinguishment Of Warrant Liability LossOnExtinguishmentOfWarrantLiability		usd
	crkn	Loss On Extinguishment Of Warrant Liability LossOnExtinguishmentOfWarrantLiability		usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives		usd
CY2022Q3	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives		usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives		usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2022Q3	crkn	Change In Fair Value Of Notes1 ChangeInFairValueOfNotes1		usd
	crkn	Change In Fair Value Of Notes1 ChangeInFairValueOfNotes1		usd
CY2022Q3	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives		usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives		usd
CY2022Q3	us-gaap	Other Expenses OtherExpenses		usd
	us-gaap	Other Expenses OtherExpenses		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments		usd
CY2022Q3	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments		usd
	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments		usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1554554	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3349195	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	250832	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	266872	shares
	crkn	Deemed Dividend For Repricing Of Series D Preferred Stock DeemedDividendForRepricingOfSeriesDPreferredStock		usd
	crkn	Issuance Of Common Stock In Connection With Series Ab Dividens IssuanceOfCommonStockInConnectionWithSeriesABDividens		usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
	crkn	Conversion Of Series F Preferred Stock Into Common Stocks ConversionOfSeriesFPreferredStockIntoCommonStocks		usd
	crkn	Conversion Of Series F1 Preferred Stock Into Common Stock ConversionOfSeriesF1PreferredStockIntoCommonStock		usd
	crkn	Stock Issuance Of Common Stock To Settle Commitment Shares StockIssuanceOfCommonStockToSettleCommitmentShares		usd
	crkn	Stock Issued During Period Reverse Stock Split Rounding StockIssuedDuringPeriodReverseStockSplitRounding		usd
CY2023Q3	crkn	Stock Issuance Of Common Stock To Settle Commitment Shares StockIssuanceOfCommonStockToSettleCommitmentShares		usd
CY2023Q3	crkn	Conversion Of Series F Preferred Stock Into Common Stocks ConversionOfSeriesFPreferredStockIntoCommonStocks		usd
CY2023Q3	crkn	Conversion Of Series F1 Preferred Stock Into Common Stock ConversionOfSeriesF1PreferredStockIntoCommonStock		usd
CY2023Q3	crkn	Stock Issued During Period Reverse Stock Split Rounding StockIssuedDuringPeriodReverseStockSplitRounding		usd
	crkn	Loss On Extinguishment Of Warrant Liability LossOnExtinguishmentOfWarrantLiability		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	crkn	Change In Fair Value Of Notes ChangeInFairValueOfNotes		usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
	us-gaap	Interest Expense Other InterestExpenseOther		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
	crkn	Proceeds From The Issuance Of Q3 Demand Notes ProceedsFromTheIssuanceOfQ3DemandNotes		usd
	crkn	Proceeds From Issuance Of Series F1 Preferred Stock Net Of Fees ProceedsFromIssuanceOfSeriesF1PreferredStockNetOfFees		usd
	crkn	Proceeds From Issuance Of Series F2 Preferred Stock ProceedsFromIssuanceOfSeriesF2PreferredStock		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	crkn	Issuance Of Series E Preferred Stock In Connection With Line Of Credit IssuanceOfSeriesEPreferredStockInConnectionWithLineOfCredit		usd
	crkn	Issuance Of Common Stock In Connection With Equity Line Of Credits IssuanceOfCommonStockInConnectionWithEquityLineOfCredits		usd
	crkn	Issuance Of Series F Preferred Stock In Connection With Exchange Of Series D Preferred Stock IssuanceOfSeriesFPreferredStockInConnectionWithExchangeOfSeriesDPreferredStock		usd
	crkn	Issuance Of Common Stock In Connection With Conversion Of Notes IssuanceOfCommonStockInConnectionWithConversionOfNotes		usd
	crkn	Issuance Of Common Stock In Connection With Senior Secured Notes Settlement IssuanceOfCommonStockInConnectionWithSeniorSecuredNotesSettlement		usd
	crkn	Issuance Of Common Stock Warrants In Connection With Sloc IssuanceOfCommonStockWarrantsInConnectionWithSLOC		usd
	crkn	Commitment To Issue Shares Of Common Stock In Connection With Demand Notes CommitmentToIssueSharesOfCommonStockInConnectionWithDemandNotes		usd
	crkn	Issuance Of Common Stock Warrants In Connection With Consideration Payable IssuanceOfCommonStockWarrantsInConnectionWithConsiderationPayable		usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable		usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable		usd
	us-gaap	Professional Fees ProfessionalFees		usd
CY2022Q4	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross		usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent		usd
CY2023Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent		usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent		usd
CY2023Q3	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent		usd
	crkn	Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeited Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2022Q4	crkn	Share Based Compensation Arrangement By Share Based Payment Award Warrant Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantOutstandingIntrinsicValue		usd
CY2023Q3	crkn	Share Based Compensation Arrangement By Share Based Payment Award Issued In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardIssuedInPeriodGrantDateIntrinsicValue		usd
CY2023Q3	crkn	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm
CY2023Q3	crkn	Share Based Compensation Arrangement By Share Based Payment Award Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisesInPeriodTotalIntrinsicValue		usd
CY2023Q3	crkn	Share Based Compensation Arrangement By Share Based Payment Award Warrant Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantOutstandingIntrinsicValue		usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001761696

Files In Submission

Name	View Source	Status
0001213900-23-087009-index-headers.html	Edgar Link	pending
0001213900-23-087009-index.html	Edgar Link	pending
0001213900-23-087009.txt	Edgar Link	pending
0001213900-23-087009-xbrl.zip	Edgar Link	pending
crkn-20230930.xsd	Edgar Link	pending
f10q0923ex31-1_crown.htm	Edgar Link	pending
f10q0923ex31-2_crown.htm	Edgar Link	pending
f10q0923ex32-1_crown.htm	Edgar Link	pending
f10q0923ex32-2_crown.htm	Edgar Link	pending
f10q0923_crownelec.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
crkn-20230930_pre.xml	Edgar Link	unprocessable
crkn-20230930_def.xml	Edgar Link	unprocessable
crkn-20230930_cal.xml	Edgar Link	unprocessable
crkn-20230930_lab.xml	Edgar Link	unprocessable
f10q0923_crownelec_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRKN
Crown Electrokinetics Corp. Stock $crkn

2023 Q4 Form 10-Q Financial Statement

#000121390023087009 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRKN Crown Electrokinetics Corp. Stock $crkn

2023 Q4 Form 10-Q Financial Statement

#000121390023087009 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRKN
Crown Electrokinetics Corp. Stock $crkn